A promising treatment, retatrutide, is generating considerable excitement within the Oz weight control community. Designed by Lilly , this dual GIP and GLP-1 receiver appears to offer more impressive results than existing therapies. Early scientific trials have shown exceptional diminutions in body mass, raising the for a new approach to managin… Read More